Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex

  • Hans D. de Boer
  • Jacques J. Driessen
  • Jan van Egmond
  • Leo H. D. J. Booij
  • François Donati
Correspondence

References

  1. 1.
    Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? (Editorial). Can J Anesth 2007; 54: 689–95.PubMedGoogle Scholar
  2. 2.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Driessen JJ, Booij LH. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation. Br J Anaesth 2006; 97: 681–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695–703.PubMedCrossRefGoogle Scholar
  4. 4.
    de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006; 96: 473–9.PubMedCrossRefGoogle Scholar

Reference

  1. 1.
    Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? (Editorial). Can J Anesth 2007; 54: 689–95.PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 2008

Authors and Affiliations

  • Hans D. de Boer
    • 1
  • Jacques J. Driessen
    • 1
  • Jan van Egmond
    • 1
  • Leo H. D. J. Booij
    • 1
  • François Donati
    • 2
  1. 1.Radboud University Medical Center NijmegenNijmegenthe Netherlands
  2. 2.University of MontrealMontrealCanada

Personalised recommendations